SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-23-003702
Filing Date
2023-05-25
Accepted
2023-05-25 16:04:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT sunshine_s3.htm S-3 136806
2 OPINION OF ANDREW I. TELSEY, P.C. sunshine_ex0501.htm EX-5.1 9731
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM sunshine_ex2301.htm EX-23.1 2060
4 CALCULATION OF FILING FEE TABLE sunshine_ex107.htm EX-FILING FEES 10750
5 GRAPHIC image_002.jpg GRAPHIC 3254
6 GRAPHIC image_001.jpg GRAPHIC 7392
  Complete submission text file 0001683168-23-003702.txt   175514
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272197 | Film No.: 23960396
SIC: 2834 Pharmaceutical Preparations